7Baggers
 Published on: 2025-11-18 04:46:49  newser.com Tue, 18 Nov 2025 10:46:49 GMT
 BeiGene (688235.SH) has granted restricted share units.  富途牛牛 Sun, 16 Nov 2025 09:32:17 GMT
 BeiGene(ONC.US) Officer Sells US$5.85 Million in Common Stock  富途牛牛 Sat, 15 Nov 2025 00:48:28 GMT
 CLSA Reaffirms Their Buy Rating on BeiGene Ltd (6160)  The Globe and Mail Tue, 11 Nov 2025 00:39:38 GMT
 Morgan Stanley Sticks to Their Buy Rating for BeiGene Ltd (6160)  The Globe and Mail Tue, 11 Nov 2025 00:39:38 GMT
 UBS Keeps Their Buy Rating on BeiGene Ltd (6160)  The Globe and Mail Tue, 11 Nov 2025 00:39:37 GMT
 beigene’s earnings call: record growth and positive outlook  TipRanks Fri, 07 Nov 2025 01:02:09 GMT
 BeiGene’s Earnings Call: Record Growth and Positive Outlook  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment  Investor's Business Daily Mon, 27 Oct 2025 07:00:00 GMT
 this ibd 50 stock, up 90% in 2025, is winning against cancer  Investor's Business Daily Mon, 27 Oct 2025 07:00:00 GMT

BeiGene, Ltd
(NASDAQ:BGNE) 

BGNE stock logo

BeiGene, Ltd., a commercial-stage biotechnology company, engages in discovering, developing, manufacturing, and commercializing medicines for cancer therapeutics in the People's Republic of China and the United States. Its commercial products include BRUKINSA to treat relapsed/refractory (R/R) mantl...

Founded: 2010
Full Time Employees: 9,400 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends